JP2016028090A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016028090A5 JP2016028090A5 JP2015187057A JP2015187057A JP2016028090A5 JP 2016028090 A5 JP2016028090 A5 JP 2016028090A5 JP 2015187057 A JP2015187057 A JP 2015187057A JP 2015187057 A JP2015187057 A JP 2015187057A JP 2016028090 A5 JP2016028090 A5 JP 2016028090A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament according
- treatment
- emetic
- subject
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1004020.2A GB201004020D0 (en) | 2010-03-11 | 2010-03-11 | New therapeutic use |
| GB1004020.2 | 2010-03-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556586A Division JP5886213B2 (ja) | 2010-03-11 | 2011-03-10 | 鎮吐薬としてのアミスルプリドの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016028090A JP2016028090A (ja) | 2016-02-25 |
| JP2016028090A5 true JP2016028090A5 (enExample) | 2016-07-28 |
| JP6279526B2 JP6279526B2 (ja) | 2018-02-14 |
Family
ID=42136792
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556586A Active JP5886213B2 (ja) | 2010-03-11 | 2011-03-10 | 鎮吐薬としてのアミスルプリドの使用 |
| JP2015187057A Active JP6279526B2 (ja) | 2010-03-11 | 2015-09-24 | 鎮吐薬としてのアミスルプリドの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012556586A Active JP5886213B2 (ja) | 2010-03-11 | 2011-03-10 | 鎮吐薬としてのアミスルプリドの使用 |
Country Status (26)
| Country | Link |
|---|---|
| US (12) | US9084765B2 (enExample) |
| EP (3) | EP2567690B1 (enExample) |
| JP (2) | JP5886213B2 (enExample) |
| KR (1) | KR101738201B1 (enExample) |
| CN (1) | CN102892407B (enExample) |
| AU (1) | AU2011225898B2 (enExample) |
| BR (1) | BR112012022746B1 (enExample) |
| CA (1) | CA2792392C (enExample) |
| CY (3) | CY1115485T1 (enExample) |
| DK (3) | DK2796171T3 (enExample) |
| EA (1) | EA030335B1 (enExample) |
| ES (3) | ES2496099T3 (enExample) |
| GB (1) | GB201004020D0 (enExample) |
| HR (3) | HRP20140744T1 (enExample) |
| HU (1) | HUE037088T2 (enExample) |
| IL (1) | IL221746A (enExample) |
| LT (1) | LT2796171T (enExample) |
| MX (3) | MX2012010411A (enExample) |
| NO (1) | NO2796171T3 (enExample) |
| NZ (1) | NZ602279A (enExample) |
| PL (3) | PL2544657T3 (enExample) |
| PT (3) | PT2544657E (enExample) |
| RS (3) | RS53466B (enExample) |
| SI (3) | SI2567690T1 (enExample) |
| SM (3) | SMT201800188T1 (enExample) |
| WO (1) | WO2011110854A2 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201004020D0 (en) | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
| CN104435861A (zh) * | 2014-12-22 | 2015-03-25 | 济南伟传信息技术有限公司 | 一种治疗妊娠剧吐的茶 |
| GB201506116D0 (en) * | 2015-04-10 | 2015-05-27 | Acacia Pharma Ltd | Kit and combination therapy for nausea and vomiting |
| EP3344962A4 (en) | 2015-09-02 | 2019-03-13 | California Institute of Technology | METHOD AND DEVICE FOR THE SPECTROSCOPIC DETECTION OF LOW CONCENTRATIONS OF SULFUR HYDROGEN GAS |
| GB201618425D0 (en) * | 2016-11-01 | 2016-12-14 | Acacia Pharma Ltd | method |
| GB201702250D0 (en) * | 2017-02-10 | 2017-03-29 | Acacia Pharma Ltd | Method |
| KR20200110317A (ko) | 2017-12-05 | 2020-09-23 | 선오비온 파마슈티컬스 인코포레이티드 | 결정형 및 이의 제조 방법 |
| CN118593482A (zh) | 2017-12-05 | 2024-09-06 | 赛诺维信制药公司 | 非外消旋混合物及其用途 |
| WO2020247603A1 (en) * | 2019-06-04 | 2020-12-10 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| AU2020286441A1 (en) | 2019-06-04 | 2022-01-06 | Sunovion Pharmaceuticals Inc. | Modified release formulations and uses thereof |
| WO2022008901A1 (en) | 2020-07-06 | 2022-01-13 | Acacia Pharma Ltd | Therapy of post-operative nausea and vomiting |
| EP4496797A1 (en) | 2022-03-21 | 2025-01-29 | Gasherbrum Bio, Inc. | 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes |
| EP4508047A1 (en) | 2022-04-14 | 2025-02-19 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2024125602A1 (en) | 2022-12-15 | 2024-06-20 | Gasherbrum Bio, Inc. | Salts and solid forms of a compound having glp-1 agonist activity |
| WO2024131869A1 (en) | 2022-12-22 | 2024-06-27 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| CN120693338A (zh) | 2022-12-22 | 2025-09-23 | 加舒布鲁姆生物公司 | 杂环的glp-1激动剂 |
| IL322686A (en) | 2023-02-16 | 2025-10-01 | Gasherbrum Bio Inc | Heterocyclic glp-1 agonists |
| US20250019389A1 (en) | 2023-06-30 | 2025-01-16 | Gasherbrum Bio, Inc. | Heterocyclic agonists |
| AR133241A1 (es) | 2023-07-13 | 2025-09-10 | Aconcagua Bio Inc | Compuestos, composiciones y métodos |
| TW202521528A (zh) | 2023-07-13 | 2025-06-01 | 美商雅空嘉閣生物公司 | 化合物、組合物及方法 |
| WO2025045208A1 (en) | 2023-08-31 | 2025-03-06 | Gasherbrum Bio, Inc. | Heteroaryl-heterocycloalkyl-based glp-1 agonists |
| WO2025137307A1 (en) | 2023-12-20 | 2025-06-26 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
| WO2025171340A1 (en) | 2024-02-08 | 2025-08-14 | Aconcagua Bio, Inc. | The treatment of calcitonin- and/or amylin-receptor associated conditions |
| WO2025171341A2 (en) | 2024-02-08 | 2025-08-14 | Aconcagua Bio, Inc. | Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity |
| WO2025189141A1 (en) | 2024-03-08 | 2025-09-12 | Annapurna Bio, Inc. | Methods for treating obesity and increasing weight loss |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2415099A1 (fr) * | 1978-01-20 | 1979-08-17 | Ile De France | Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes |
| US6169094B1 (en) * | 1998-07-14 | 2001-01-02 | Sanofi-Synthelabo | Compositions of (S) (-)-amisulpride |
| DE10163421A1 (de) * | 2001-12-21 | 2003-07-31 | Gruenenthal Gmbh | Verwendung von (+)-(1S,2S)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)phenol als Antiemetikum |
| DE102005013726A1 (de) * | 2005-03-22 | 2006-09-28 | Grünenthal GmbH | Transdermale therapeutische Systeme mit verbesserter Verträglichkeit |
| GB0506800D0 (en) * | 2005-04-04 | 2005-05-11 | Merck Sharp & Dohme | New uses |
| WO2007067714A2 (en) * | 2005-12-08 | 2007-06-14 | The Mclean Hospital Corporation | Treatment of sequelae of psychiatric disorders |
| AU2007211091B8 (en) | 2006-01-27 | 2013-08-29 | Adare Pharmaceuticals, Inc. | Drug delivery systems comprising weakly basic selective serotonin 5-HT3 blocking agent and organic acids |
| EP1988883A1 (fr) * | 2006-02-17 | 2008-11-12 | Trimaran Limited | Nouvelles compositions pharmaceutiques destinees a optimiser des traitements de substitution et elargir la pharmacopee au traitement global des addictions |
| US7825156B2 (en) * | 2007-02-02 | 2010-11-02 | Copharms | Method of treating bipolar depression with a benzamide derivative |
| EP2240022B1 (en) * | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
| US8138169B2 (en) * | 2008-04-11 | 2012-03-20 | Comgenrx, Inc. | Combination therapy for bipolar disorder |
| GB201004020D0 (en) * | 2010-03-11 | 2010-04-21 | Acacia Pharma Ltd | New therapeutic use |
-
2010
- 2010-03-11 GB GBGB1004020.2A patent/GB201004020D0/en not_active Ceased
-
2011
- 2011-03-10 SI SI201130237T patent/SI2567690T1/sl unknown
- 2011-03-10 DK DK14173186.9T patent/DK2796171T3/en active
- 2011-03-10 BR BR112012022746-7A patent/BR112012022746B1/pt active IP Right Grant
- 2011-03-10 MX MX2012010411A patent/MX2012010411A/es active IP Right Grant
- 2011-03-10 MX MX2015003664A patent/MX370629B/es unknown
- 2011-03-10 AU AU2011225898A patent/AU2011225898B2/en active Active
- 2011-03-10 ES ES12188047.0T patent/ES2496099T3/es active Active
- 2011-03-10 PT PT117097931T patent/PT2544657E/pt unknown
- 2011-03-10 PL PL11709793T patent/PL2544657T3/pl unknown
- 2011-03-10 SI SI201130236T patent/SI2544657T1/sl unknown
- 2011-03-10 PL PL14173186T patent/PL2796171T3/pl unknown
- 2011-03-10 ES ES11709793.1T patent/ES2496092T3/es active Active
- 2011-03-10 PT PT141731869T patent/PT2796171T/pt unknown
- 2011-03-10 RS RS20140410A patent/RS53466B/sr unknown
- 2011-03-10 MX MX2019015396A patent/MX388787B/es unknown
- 2011-03-10 HU HUE14173186A patent/HUE037088T2/hu unknown
- 2011-03-10 NO NO14173186A patent/NO2796171T3/no unknown
- 2011-03-10 DK DK11709793.1T patent/DK2544657T3/da active
- 2011-03-10 EA EA201290833A patent/EA030335B1/ru unknown
- 2011-03-10 PT PT121880470T patent/PT2567690E/pt unknown
- 2011-03-10 LT LTEP14173186.9T patent/LT2796171T/lt unknown
- 2011-03-10 NZ NZ602279A patent/NZ602279A/en unknown
- 2011-03-10 SI SI201131446T patent/SI2796171T1/en unknown
- 2011-03-10 JP JP2012556586A patent/JP5886213B2/ja active Active
- 2011-03-10 SM SM20180188T patent/SMT201800188T1/it unknown
- 2011-03-10 EP EP12188047.0A patent/EP2567690B1/en active Active
- 2011-03-10 HR HRP20140744AT patent/HRP20140744T1/hr unknown
- 2011-03-10 EP EP14173186.9A patent/EP2796171B1/en active Active
- 2011-03-10 EP EP11709793.1A patent/EP2544657B1/en active Active
- 2011-03-10 PL PL12188047T patent/PL2567690T3/pl unknown
- 2011-03-10 DK DK12188047.0T patent/DK2567690T3/da active
- 2011-03-10 ES ES14173186.9T patent/ES2665418T3/es active Active
- 2011-03-10 CN CN201180018552.XA patent/CN102892407B/zh not_active Ceased
- 2011-03-10 KR KR1020127024111A patent/KR101738201B1/ko active Active
- 2011-03-10 CA CA2792392A patent/CA2792392C/en active Active
- 2011-03-10 RS RS20180349A patent/RS57032B1/sr unknown
- 2011-03-10 RS RS20140411A patent/RS53467B/sr unknown
- 2011-03-10 WO PCT/GB2011/050472 patent/WO2011110854A2/en not_active Ceased
-
2012
- 2012-07-26 US US13/559,168 patent/US9084765B2/en active Active
- 2012-07-26 US US13/559,253 patent/US8686019B2/en active Active
- 2012-09-02 IL IL221746A patent/IL221746A/en active IP Right Grant
-
2014
- 2014-02-04 US US14/172,194 patent/US9119836B2/en active Active
- 2014-08-01 HR HRP20140745AT patent/HRP20140745T1/hr unknown
- 2014-08-14 CY CY20141100656T patent/CY1115485T1/el unknown
- 2014-08-14 CY CY20141100657T patent/CY1115487T1/el unknown
- 2014-09-10 SM SM201400126T patent/SMT201400126B/xx unknown
- 2014-09-10 SM SM201400127T patent/SMT201400127B/xx unknown
-
2015
- 2015-07-29 US US14/812,148 patent/US9545426B2/en active Active
- 2015-09-24 JP JP2015187057A patent/JP6279526B2/ja active Active
-
2016
- 2016-12-09 US US15/374,174 patent/US9889118B2/en active Active
-
2017
- 2017-10-23 US US15/790,481 patent/US10085970B2/en active Active
-
2018
- 2018-03-14 HR HRP20180436TT patent/HRP20180436T1/hr unknown
- 2018-04-18 CY CY20181100416T patent/CY1120170T1/el unknown
- 2018-08-20 US US16/105,268 patent/US10525033B2/en active Active
-
2019
- 2019-11-27 US US16/697,986 patent/US20200093792A1/en not_active Abandoned
-
2020
- 2020-09-08 US US17/013,987 patent/US20210228543A1/en not_active Abandoned
-
2022
- 2022-06-07 US US17/834,000 patent/US20220296570A1/en not_active Abandoned
-
2023
- 2023-01-11 US US18/095,612 patent/US12194022B2/en active Active
-
2024
- 2024-12-06 US US18/972,484 patent/US20250186394A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016028090A5 (enExample) | ||
| JP2016106150A5 (enExample) | ||
| JP2016501828A5 (enExample) | ||
| JP2009525343A5 (enExample) | ||
| HRP20180436T1 (hr) | Upotreba amisulprida u liječenju mučnine i povraćanja uzrokovanih opijatima | |
| JP2014040437A5 (enExample) | ||
| HRP20160361T1 (hr) | Terapija u kombinaciji s antitumorskim alkaloidom | |
| JP2013155188A5 (enExample) | ||
| JP2015110588A5 (enExample) | ||
| JP2013151541A5 (enExample) | ||
| JP2016185995A5 (enExample) | ||
| JP2017506624A5 (enExample) | ||
| JP2015523407A5 (enExample) | ||
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| JP2015522522A5 (enExample) | ||
| JP2012131811A5 (enExample) | ||
| JP2013166781A5 (enExample) | ||
| EP4606430A3 (en) | Use of il-22 dimer in manufacture of a medicament for intravenous administration | |
| JP2016532516A5 (enExample) | ||
| MY204827A (en) | Semaglutide in medical therapy | |
| JP2016527312A5 (ja) | ヒスタミンｈ４受容体を介してもたらされた掻痒状態を治療するための医薬組成物 | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| MX2016014695A (es) | Combinaciones de bromuro de tiotropio, formoterol y budesonida para el tratamiento de enfermedad pulmonar obstructiva cronica. | |
| JP2014148552A5 (enExample) | ||
| JP2019501194A5 (enExample) |